Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Ann Pharm Fr ; 80(1): 81-88, 2022 Jan.
Artículo en Francés | MEDLINE | ID: mdl-33961827

RESUMEN

INTRODUCTION: The use of porous metal cones (PMC) to fill bone loss during knee replacements is increasing, but these medical devices are not reimbursed in addition to diagnosis related tariffs (DRTs). The economic impact of PMC may be significant for hospitals. MATERIAL AND METHODS: This multicenter observational study includes all patients who benefited of a total knee prosthesis, with reconstruction by PMC, between June 2014 and June 2019, in two French university hospitals. The costs of each diagnosis related group (DRG) was evaluated using the "étude nationale des coûts à méthodologie commune (ENC)". The PMC costs were compared with the amounts of DRG and with the fares perceived by the hospital from the French sickness fund (DRTs). RESULTS: 96 patients (103 stays) benefited from the implantation of 195 cones. The hospital incomes were 10,970±1401€ /stay. Spending associated with PMC represented 35% of DRGs and 44% of DRTs. The average additional cost related to the cones was 2709±1138€ /stay. If the reconstructions had been performed by allograft, the average gain for hospitals would have been 108€ /stay. CONCLUSION: If PMC have clinical benefits for surgeons in reducing the incidence of revision, this study shows the inadequacy of the funding of these devices for French hospitals. This suggests the need to expand the possibilities of supporting innovative technologies.


Asunto(s)
Artroplastia de Reemplazo de Rodilla , Prótesis de la Rodilla , Análisis Costo-Beneficio , Humanos , Porosidad , Diseño de Prótesis , Reoperación
2.
Pharmazie ; 76(4): 150-154, 2021 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-33849699

RESUMEN

In pediatric wards, topiramate is prescribed as an antiepileptic at non-licensed dosages. Compounding is the best way to obtain topiramate drug adapted to pediatric patients, but this practice requires to control the quality of batches and to manage a stability study to establish a beyond-use-date. With this objective, 6 mg. mL 1 topiramate oral suspension and 9 mg capsules were realized, and our laboratory was mandated for their quality control. Previously described dosing methods did not allow us to determine topiramate content in prescribed preparations. An original HPLC-UV derivatization dosing method of topiramate was validated and was proved to be stability indicating. This derivatization methodology, but also total aerobic microbial count (TAMC) and total combined yeasts and mold count (TYMC) allowed the quality control of topiramate capsules and topiramate suspension. Beyond-use-dates can be attributed with regards to United States Pharmacopoeia recommendations, and a stability study was performed on 6 mg. mL-1 topiramate suspension to confirm empirical data. Topiramate pediatric suspension was found to be stable for two months at +2/+8 °C, one month after opening and one day at ambient temperature.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Cromatografía Líquida de Alta Presión/métodos , Composición de Medicamentos/métodos , Topiramato/administración & dosificación , Administración Oral , Anticonvulsivantes/análisis , Anticonvulsivantes/química , Cápsulas , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Control de Calidad , Suspensiones , Temperatura , Factores de Tiempo , Topiramato/análisis , Topiramato/química
3.
J Hosp Infect ; 106(2): 258-263, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32745593

RESUMEN

BACKGROUND: To reduce the shortage of N95 respirators and surgical masks during the COVID-19 pandemic, stockpiled equipment beyond its expiry date could be released. AIM: Centralized testing of batches of expired surgical masks and N95 for safe distribution to hospital departments saving users time. METHODS: Tests of compliance with health authority directives were developed and carried out on 175 batches of N95 masks and 31 batches of surgical masks from 12th March 2020 to 16 April 2020. Five quality-control tests were performed on batch samples to check: packaging integrity, mask appearance, breaking strength of elastic ties and strength of nose clip test, and face-fit. FINDINGS: Forty-nine per cent of FFP2 mask batches were compliant with directives, 32% of batches were compliant but with some concerns and 19% of batches were non-compliant. For surgical masks, 58% of batches were compliant, 39% of batches compliant but with concerns and 3% of batches were non-compliant. CONCLUSION: The main areas of non-compliance were the breaking strength of the elastic ties and the nose clip but these alone were not considered to make the masks unacceptable. Only mask appearance and face-fit results were decisive non-compliance criteria.


Asunto(s)
Infecciones por Coronavirus/prevención & control , Adhesión a Directriz , Máscaras/normas , Exposición Profesional/prevención & control , Pandemias/prevención & control , Neumonía Viral/prevención & control , Control de Calidad , Dispositivos de Protección Respiratoria/normas , Ventiladores Mecánicos/normas , Betacoronavirus , COVID-19 , Francia , Humanos , SARS-CoV-2 , Factores de Tiempo
4.
Bone Joint J ; 101-B(7): 848-851, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31256673

RESUMEN

AIMS: The aims of this study were to compare the mean duration of antibiotic release and the mean zone of inhibition between vancomycin-loaded porous tantalum cylinders and antibiotic-loaded bone cement at intervals, and to evaluate potential intrinsic antimicrobial properties of tantalum in an in vitro medium environment against methicillin-sensitive Staphylococcus aureus (MSSA). MATERIALS AND METHODS: Ten porous tantalum cylinders and ten cylinders of cement were used. The tantalum cylinders were impregnated with vancomycin, which was also added during preparation of the cylinders of cement. The cylinders were then placed on agar plates inoculated with MSSA. The diameter of the inhibition zone was measured each day, and the cylinders were transferred to a new inoculated plate. Inhibition zones were measured with a Vernier caliper and using an automated computed evaluation, and the intra- and interobserver reproducibility were measured. The mean inhibition zones between the two groups were compared with Wilcoxon's test. RESULTS: MSSA was inhibited for 12 days by the tantalum cylinders and for nine days by the cement cylinders. At day one, the mean zone of inhibition was 28.6 mm for the tantalum and 19.8 mm for the cement group (p < 0.001). At day ten, the mean zone of inhibition was 3.8 mm for the tantalum and 0 mm for the cement group (p < 0.001). The porous tantalum cylinders soaked only with phosphate buffered solution showed no zone of inhibition. CONCLUSION: Compared with cement, tantalum could release antibiotics for longer. Further studies should assess the advantages of using antibiotic-loaded porous tantalum implants at revision arthroplasty. Cite this article: Bone Joint J 2019;101-B:848-851.


Asunto(s)
Antibacterianos/administración & dosificación , Cementos para Huesos , Sistemas de Liberación de Medicamentos , Staphylococcus aureus/efectos de los fármacos , Tantalio , Vancomicina/administración & dosificación , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Artroplastia de Reemplazo/instrumentación , Humanos , Prótesis Articulares , Pruebas de Sensibilidad Microbiana , Variaciones Dependientes del Observador , Infecciones Relacionadas con Prótesis/prevención & control , Factores de Tiempo , Vancomicina/farmacología , Vancomicina/uso terapéutico
5.
Artículo en Francés | AIM (África) | ID: biblio-1268739

RESUMEN

Cet article rapporte des extraits de protocoles et d'entretiens et questionnaires realises aupres des jeunes lyceens algerois


Asunto(s)
Adolescente , Instituciones Académicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA